Remove authors zs-associates
article thumbnail

Why real patient centricity is more essential than ever before

pharmaphorum

Sharon Suchotliff is an associate principal at ZS Associates and co-author with Hensley Evans, who leads the global patient and consumer health practice at ZS, of Reinventing Patient Centricity: Bringing patient-led business models to life.

article thumbnail

Beyond the Early Adopters: Mainstream Adoption of AI in Life Sciences Training

Quantified

Andreas Mueller, former CIO of Novartis and an Advisory Board Member with expertise in digital transformation at major firms like Deloitte and ZS Associates. Leaders, buyers, and analysts routinely cite it as an authority. She shared her perspective as an industry veteran with a background as a Primary Care Clinical Pharmacist.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Will Pharma turn to tech for faster market access reporting?

Clarify Health

I sat down with Colin Taggart, Director of Life Sciences Implementation at Clarify Health, who previously spent five years at ZS Associates as a market access consultant to top 20 pharmaceutical companies. prior authorizations, step edits, and tiering).

article thumbnail

Will Pharma turn to tech for faster market access reporting?

Clarify Health

I sat down with Colin Taggart, Director of Life Sciences Implementation at Clarify Health, who previously spent five years at ZS Associates as a market access consultant to top 20 pharmaceutical companies. prior authorizations, step edits, and tiering).

article thumbnail

Global Biopharma Launches in the New World Order

PM360

But multiple companies have withdrawn marketing authorization in ex-U.S. ZS’ 2022 State of AI in Life Sciences Survey shows that 47% of AI use cases are in drug discovery. ZS’ research tracking launches from 2015-2020 shows that novel product launches are just as likely to underperform as overperform (see Figure 1).